Peyronies Society Forums

Please login or register.

Login with username, password and session length
Advanced search  


Please go to PROFILE then FORUM PROFILE to replace your signature line text with your profile info such as age, date of onset, symptoms, treatments tried, etc

Pages: [1]   Go Down

Author Topic: New study on restorex efficacy on treating peyronies disease!!!! 27/March 2019  (Read 346 times)

0 Members and 1 Guest are viewing this topic.


  • Think Tank
  • **
  • Country: ca
  • Offline Offline
  • Gender: Male
  • Posts: 1444
  • #whateverittakes

Outcomes Of A Novel Penile Traction Device (Restorex) In Men With Peyronie's Disease: A Randomized, Single-Blinded, Controlled Trial.
Ziegelmann M1, Savage J1, Toussi A1, Alom M1, Yang D1, Kohler T1, Trost L1.
Author information

Current penile traction therapy (PTT) devices have significant limitations, including a need to utilize 3-8 hours/day. Given these issues, a novel PTT device (RestoreX) was developed in cooperation with Mayo Clinic.

A randomized, controlled, single-blinded, intent-to-treat trial (NCT03389854) was conducted with Peyronie's Disease (Peyronies Disease) men assigned to RestoreX 30-90 min/day or no therapy for 3 months. Inclusion criteria was ≥30° curvature, with no exclusions for complex curvatures, hourglass, prior Peyronies Disease therapy/surgery, or calcification. The primary outcome was safety, and secondary outcomes were penile length, curvature, and questionnaire responses.

110 men were randomized 3:1 to PTT or control. Cohorts were well-matched: mean age 58.4 years, Peyronies Disease duration 49.7 months, and curvature 59.3°. Overall, PTT was well tolerated, with only transient and mild adverse events reported. At 3-months, PTT men demonstrated significant improvements over controls in length (1.5 vs 0 cm, p<0.001), curve (-11.7° vs +1.3°, p<0.01), and erectile function (IIEF-EFD +4.3 vs -0.7 among men with erectile dysfunction [Erectile Dysfunction], p=0.01). Overall, 77% of PTT men experienced improved curvature (responders: mean -17.2°, 28.2%), while 94% achieved increased length (+1.6 cm, 10.9%). Counter-bending and the white-line indicator improved efficacy, validating key device innovations. Of those previously using other PTT devices, 100% preferred RestoreX.

PTT with RestoreX 30-90 min/day is safe and results in significant and clinically-meaningful improvements in penile curvature and length in Peyronies Disease men and erectile function in Erectile Dysfunction/Peyronies Disease men, with no significant adverse events. These data represent the only to report improvements with any device <3-8 hours/day.

This is very good news!
Pages: [1]   Go Up

Related Topics

  Subject / Started by Replies Last post
0 Replies
Last post April 26, 2006, 11:39:54 PM
by Hawk
3 Replies
Last post December 01, 2015, 05:17:55 PM
by james1947
26 Replies
Last post May 07, 2019, 11:19:06 PM
by TonySa